Enanta Pharmaceuticals Inc
What this means
- Net loss in 2025Net loss of $81.9M for the year (2024: −$116M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
- How to search SEC EDGAR: company filings, full-text search and alertsguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $65.3M | $67.6M |
| Net income (loss) | −$81.9M | −$116M |
| Total assets | $330M | $349M |
| Total liabilities | $203M | $237M |
| Stockholders’ equity | $127M | $112M |
| Cash and equivalents | $37.4M | $84.3M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends September 30. Check the annual report for the exact figures and periods.
- Name as filed
- ENANTA PHARMACEUTICALS INC
- CIK
- 0001177648
- Tickers
- ENTA
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- —
- Business address
- Watertown, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- September 30
- Last annual report
- 10-K for the period ended Sep 30, 2026
- Last quarterly report
- 10-Q for the quarter ended Jun 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 18, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-K · filed Nov 18, 2026 · filing · edition of Nov 18, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 16, 2026 · filing · edition of Nov 16, 2026
- Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 28, 2026 · filing
- Form 10-Q · filed Aug 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 10, 2026 · filing
- Form 10-Q · filed May 13, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 11, 2026 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Mar 12, 2026 · filing
- Form 10-Q · filed Feb 11, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 9, 2026 · filing
- Form 10-K · filed Nov 19, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 17, 2025 · filing
- Form 8-K · items 5.02 · filed Aug 27, 2025 · filing
- Form 10-Q · filed Aug 13, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
- Form 10-Q · filed May 14, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 12, 2025 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Mar 17, 2025 · filing
- Form 10-Q · filed Feb 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 10, 2025 · filing
- Form 10-K · filed Nov 27, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 25, 2024 · filing
- Form 10-Q · filed Aug 7, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 5, 2024 · filing
- Form 10-Q · filed May 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 6, 2024 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Mar 12, 2024 · filing
- Form 10-Q · filed Feb 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 7, 2024 · filing
- Form 8-K · items 5.02 · filed Dec 26, 2023 · filing
- Form 10-K · filed Nov 22, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 20, 2023 · filing
- Form 10-Q · filed Aug 8, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 7, 2023 · filing
- Form 10-Q · filed May 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 8, 2023 · filing
- Form 10-Q · filed Feb 8, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 7, 2023 · filing